Featured Research

from universities, journals, and other organizations

A little adversity bodes well for those with chronic back pain, study suggests

Date:
August 6, 2010
Source:
University at Buffalo
Summary:
For people with chronic back pain, having a little adversity in your life can be protective and beneficial, according to a new study.

A new study by researchers at the University at Buffalo and the University of California, Irvine, to be published in the September issue of the journal Pain, reveals that, for people with chronic back pain, having a little adversity in your life can be protective and beneficial.

These individuals experience less physical impairment and spend less time in doctor's offices or health clinics, says the study's author Mark Seery, PhD, assistant professor of psychology at UB, who emphasizes that the key to the benefit is the experience of "some" prior adverse events as opposed to many or none at all.

"This study of 396 adults with chronic back pain (CBP) found that those with some lifetime adversity reported less physical impairment, disability and heavy utilization of health care than those who had experienced either no adversity or a high level of adversity," Seery explains.

"The data suggest that adversity-exposure also may protect against psychiatric disturbances that occur with CBP," Seery says, "and additional analyses found no alternative explanations of our findings."

In addition to Seery, the research team included Raphael J. Leo, MD, associate professor of clinical psychiatry, UB School of Medicine and Biomedical Sciences; E. Alison Holman, PhD, assistant professor of nursing sciences, UC Irvine; and Roxane Cohen Silver, PhD, professor of psychology and social behavior and medicine, UC Irvine.

The study sample was drawn from a nationally representative web-enabled, population-based panel created through traditional probability sampling techniques such as random-digit dialing by Knowledge Networks, Inc. From 2001 to 2003, assessments were administered to subjects by KN online or by mail.

The subjects had previously acknowledged a history of CBP when reporting their physical health status in an online survey. They completed a survey of lifetime exposure to 37 adverse events, including one's own or a loved one's illness/injury, sexual and non-sexual violence, bereavement, social or environmental stress, disaster and various relationship stresses.

Subjects subsequently reported self-rated functional impairment, disabled employment status, frequency of back pain treatment, prescription painkiller use and whether they currently sought treatment for comorbid psychiatric disorders.

The researchers speculate that observed patterns of relationships between adversity and CBP-related outcomes may reflect the possibility that resilience, a phenomenon largely ignored in previous CBP research, is occurring.

"It appears," says Seery, "that adversity may promote the development of psychological and social resources that help one tolerate adversity, which in this case leads to better CBP-related outcomes. It may be that the experience of prior, low-levels of adversity may cause sufferers to reappraise stressful and potentially debilitating symptoms of CBP as minor annoyances that do not substantially interfere with life."

Seery says that previous attempts to understand the persistence, refractoriness and disability associated with CBP have underscored the importance of psychosocial variables and demonstrated an association between CBP and lifetime exposure to adverse events.

"Previous research suggests that exposure to adverse life events correlates with greater CBP severity," he says. "This implies that the optimal situation would be one in which individuals have not been exposed to any adverse lifetime events.

"It appears, however, that the relationship between adversity and chronic pain is not so simple, in that experiencing some prior adversity is actually most beneficial," Seery says.


Story Source:

The above story is based on materials provided by University at Buffalo. Note: Materials may be edited for content and length.


Journal Reference:

  1. Seery et al. Lifetime exposure to adversity predicts functional impairment and healthcare utilization among individuals with chronic back pain. Pain, 2010; DOI: 10.1016/j.pain.2010.06.007

Cite This Page:

University at Buffalo. "A little adversity bodes well for those with chronic back pain, study suggests." ScienceDaily. ScienceDaily, 6 August 2010. <www.sciencedaily.com/releases/2010/08/100805172947.htm>.
University at Buffalo. (2010, August 6). A little adversity bodes well for those with chronic back pain, study suggests. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2010/08/100805172947.htm
University at Buffalo. "A little adversity bodes well for those with chronic back pain, study suggests." ScienceDaily. www.sciencedaily.com/releases/2010/08/100805172947.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins